Know Cancer

or
forgot password

    • cancer clinical trials in bakersfield, CA

    • Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Lung Neoplasm, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB, Carcinoma Non-small Cell Lung Cancer Stage IV
    Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Lung Cancer
    Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Multiple Myeloma and Plasma Cell Neoplasm
    Study Comparing GW572016 And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Breast
    Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Breast Cancer
    Study of Long-Term Peg Intron Vs. Colchicine in Non-Responders.
    34th Street Community Health Center
    Bakersfield, California 93301-1645
    Hepatitis C Virus, Advanced Fibrosis, Cirrhosis
    Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Colorectal Cancer
    GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma
    GSK Investigational Site
    Bakersfield, California 93309
    Solid Tumor Cancer, Renal Cell Carcinoma, Carcinoma, Renal Cell
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Comp Blood & Cancer Center
    Bakersfield, California 93309
    Non-Small Cell Lung Cancer
    Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Breast
    ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Breast
    Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Multiple Myeloma and Plasma Cell Neoplasm
    Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Breast
    Combination Of Lapatinib With Carboplatin, Paclitaxel and Trastuzumab In Metastatic Breast Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Breast
    Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Breast
    Study To Assess Long Term Safety Of Pazopanib
    GSK Investigational Site
    Bakersfield, California 93309
    Cancer
    Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Lung Cancer, Non-Small Cell
    Lapatinib and Bevacizumab for Metastatic Breast Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Breast
    Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Prostate, Prostate Cancer
    GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Lung Cancer, Non-Small Cell
    ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Breast, Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Breast Cancer
    Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer
    ImClone Investigational Site
    Bakersfield, California 93309
    Adenocarcinoma of the Prostate
    Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Breast
    LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations
    1200.22.28 Boehringer Ingelheim Investigational Site
    Bakersfield, California
    Carcinoma, Non-Small-Cell Lung
    Patients With Advanced Non-Small Cell Lung Cancer
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Non-Small Cell Lung Carcinoma
    LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
    GSK Investigational Site
    Bakersfield, California 93309
    or Gastro-esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease., ErbB2 (HER2) Amplified Gastric, Neoplasms, Gastrointestinal Tract, Esophageal
    Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
    GSK Investigational Site
    Bakersfield, California 93309
    Lung Cancer, Non-Small Cell
    Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer
    ImClone Investigational Site
    Bakersfield, California 93309
    Breast Cancer
    Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Breast
    Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma
    GSK Investigational Site
    Bakersfield, California 93309
    Carcinoma, Renal Cell
    Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Multiple Myeloma and Plasma Cell Neoplasm
    Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Multiple Myeloma and Plasma Cell Neoplasm
    Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia
    GSK Investigational Site
    Bakersfield, California 93309
    Leukaemia, Lymphocytic, Chronic
    A Study of IMC-A12 in Islet Cell Cancer
    ImClone Investigational Site
    Bakersfield, California 93309
    Carcinoma, Neuroendocrine Tumors
    Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
    GSK Investigational Site
    Bakersfield, California 93309
    Solid Tumors, Neoplasms, Breast, Cancer
    A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia
    GSK Investigational Site
    Bakersfield, California 93309
    Waldenstrom Macroglobulinaemia
    Treatment With Pazopanib for Neoadjuvant Breast Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Breast
    Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer
    Comprehensive Blood and Cancer Center Dept. of CBCC (2)
    Bakersfield, California 93309
    Breast Cancer
    A Study of IMC-A12 in Combination With Sorafenib in Patients With Advanced Cancer of the Liver
    ImClone Investigational Site
    Bakersfield, California 93309
    Hepatocellular Carcinoma
    Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma
    ImClone Investigational Site
    Bakersfield, California 93309
    Gastric Cancer, Adenocarcinoma
    Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
    GSK Investigational Site
    Bakersfield, California 93309
    Leukemia-relapsed or Refractory, Cancer
    A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
    Location # 043
    Bakersfield, California 93309
    Metastatic Colorectal Cancer
    Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
    GSK Investigational Site
    Bakersfield, California 93309
    Cancer
    First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin
    ImClone Investigational Site
    Bakersfield, California 93309
    Non Small Cell Lung Cancer
    Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Esophageal Cancer, Gastric Cancer
    Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
    GSK Investigational Site
    Bakersfield, California 93309
    Leukaemia, Lymphocytic, Chronic
    Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212
    GSK Investigational Site
    Bakersfield, California 93309
    Cancer
    Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
    GSK Investigational Site
    Bakersfield, California 93309
    Thrombocytopaenia
    A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma
    GSK Investigational Site
    Bakersfield, California 93309
    Melanoma
    A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
    Bakersfield Dermatology and Skin Cancer Medical Group
    Bakersfield, California 93309
    Psoriasis
    A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma
    ImClone Investigational Site
    Bakersfield, California 93309
    Gastric Cancer
    A Study of IMC-3G3 in Soft Tissue Sarcoma
    ImClone Investigational Site
    Bakersfield, California 93309
    Sarcoma, Soft Tissue
    A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer,, Primary Peritoneal Cancer or Endometrial Cancer, Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer
    Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.
    Bakersfield Dermatology and Skin Cancer Medical Center
    Bakersfield, California 93309
    Plaque Psoriasis
    A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain
    GSK Investigational Site
    Bakersfield, California 93309
    Melanoma and Brain Metastases